From Curiosity-Driven Basic Science to Application

Category Technology

tldr #

Basic research is a type of investigation seeking to understand natural phenomena. Recent discoveries, like mRNA modifications, have enabled better vaccines and saved millions of lives. Companies investing in basic research need to consider return on investment because it often takes decades for research to be translated into a new product or technology.


content #

What is basic science? .

Basic research, sometimes called fundamental research, is a type of investigation with the overarching goal of understanding natural phenomena like how cells work or how birds can fly. Scientists are asking the fundamental questions of how, why, when, where and if in order to bridge a gap in curiosity and understanding about the natural world.

Researchers sometimes conduct basic research with the hope of eventually developing a technology or drug based on that work. But what many scientists typically do in academia is ask fundamental questions with answers that may or may not ever lead to practical applications.

In the late 1920s Alexander Fleming and his colleague, Ernest Chain, isolated penicillin, the first antibiotic to treat tuberculosis.

Humans, and the animal kingdom as a whole, are wired to be curious. Basic research scratches that itch.

What are some basic science discoveries that went on to have a big influence on medicine? .

The 2023 Nobel Prize in physiology or medicine acknowledges basic science work done in the early 2000s. Karikó and Weissman’s discovery about modifying mRNA to reduce the body’s inflammatory response to it allowed other researchers to leverage it to make improved vaccines.

Tthe discovery of mRNA modification by Karikó and Weissman paved the way for the development of mRNA vaccines for conditions such as COVID-19.

Another example is the discovery of antibiotics, which was based on an unexpected observation. In the late 1920s, the microbiologist Alexander Fleming was growing a species of bacteria in his lab and found that his Petri dish was accidentally contaminated with the fungus Penicillium notatum. He noticed that wherever the fungus was growing, it impeded or inhibited the growth of the bacteria. He wondered why that was happening and subsequently went on to isolate penicillin, which was approved for medical use in the early 1940s.

Money is one of the main reasons basic science can take decades to be translated into medical technology.

This work fed into more questions that ushered in the age of antibiotics. The 1952 Nobel Prize in physiology or medicine was awarded to Selman Waksman for his discovery of streptomycin, the first antibiotic to treat tuberculosis.

Basic research often involves seeing something surprising, wanting to understand why and deciding to investigate further. Early discoveries start from a basic observation, asking the simple question of "How?" Only later are they parlayed into a medical technology that helps humanity.

Antibiotics are natural substances that can inhibit the growth and reproduction of certain Bacteria.

Why does it take so long to get from curiosity-driven basic science to a new product or technology? .

The mRNA modification discovery could be considered to be on a relatively fast track from basic science to application. Less than 15 years passed between Karikó and Weissman’s findings and the COVID-19 vaccines. The importance of their discovery came to the forefront with the pandemic and the millions of lives they saved.

In 1952 the Nobel Prize for Physiology or Medicine was awarded to Selman Waksman for his discovery of streptomycin.

Most basic research won’t reach the market until several decades after its initial publication in a science journal. One reason is because it depends on need. For example, orphan diseases that affect only a small number of people will get less attention and funding than conditions that are ubiquitous in a population, like cancer or diabetes. Companies don’t want to spend billions of dollars developing a drug that will only have a small return on their investment. Likewise, because the return on investment for basic research often isn’t clear, it can be a hard sell to suss out the money to fund such a big risk.

Most orphan diseases usually get less attention and funding than conditions that are widespread in a population.

hashtags #
worddensity #

Share